Elisenstraße 3,
Munich 80335
Germany
+49 (0) 89 747 266 0
www.maiwald.eu
info@maiwald.eu
Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T |
---|---|---|---|---|---|---|---|
Buyside (0.2/yr) | 1 | 1 | - | - | - | - | 2 |
Sellside (0.0/yr) | - | - | - | - | - | - | 0 |
2 |
Target Company | Date | Value | Type |
---|---|---|---|
Sign-up to View | 2021-04-08 | 240M USD | Life Science |
Sign-up to View | 2019-04-01 | 260M USD | Life Science |
View All >> |
Sector | # | Value | |
---|---|---|---|
Life Science | Sign-up to View | ||
Total | Sign-up to View |
State/Country | # | Value | |
---|---|---|---|
United States | Sign-up to View | ||
Massachusetts | Sign-up to View | ||
Total | Sign-up to View |
Type | # | Value | |
---|---|---|---|
Divestiture | Sign-up to View | ||
Total | Sign-up to View |
Corporate (1) | Deals |
---|---|
Sign-up to View |
2 |
Value | # | TOTAL |
---|---|---|
$100M to $1B | Sign-up to View | |
< $100M | Sign-up to View | |
TOTAL | Sign-up to View | |
Largest |
Arteaus Therapeutics LLC - Emgality Royalty $260M (2019-04-01) |